GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
South Korea flag South Korea · Delayed Price · Currency is KRW
27,050
-750 (-2.70%)
Apr 10, 2026, 3:30 PM KST

GemVax&KAEL Revenue

In the year 2025, GemVax&KAEL had annual revenue of 81.53B KRW with 30.05% growth. GemVax&KAEL had revenue of 26.16B in the quarter ending December 31, 2025, with 43.18% growth.

Revenue
81.53B
Revenue Growth
+30.05%
P/S Ratio
14.56
Revenue / Employee
447.97M
Employees
182
Market Cap
1.19T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202581.53B18.84B30.05%
Dec 31, 202462.69B-9.52B-13.18%
Dec 31, 202372.21B-3.60B-4.74%
Dec 31, 202275.80B15.43B25.56%
Dec 31, 202160.37B-5.29B-8.06%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
SFA Engineering1.63T
Creative & Innovative System407.18B
SPG Co., Ltd.341.67B
Fine Semitech280.26B
MNC Solution Co.,Ltd266.42B
Hy-Lok214.57B
Hantech171.90B
Hyulim ROBOT168.30B
Revenue Rankings